Development of vildagliptin loaded Eudragit® microspheres by screening design: in vitro evaluation

被引:26
作者
Naik J.B. [1 ]
Waghulde M.R. [1 ]
机构
[1] Department of Pharmaceutical Technology, University Institute of Chemical Technology, North Maharashtra University, Umavi Nagar, Jalgaon, 425001, Maharashtra
关键词
Encapsulation efficiency; Eudragit[!sup]®[!/sup] RS100; Microspheres; Plackett–Burman design; Vildagliptin;
D O I
10.1007/s40005-017-0355-3
中图分类号
学科分类号
摘要
The aim of this study was to develop and characterize sustained release vildagliptin (VLG) loaded Eudragit® RS-100 microspheres. The microspheres were prepared by single emulsion [oil-in-oil (O/O)] solvent evaporation method. Plackett–Burman design (PBD) was employed by using Design-Expert® Software to screen and understand impact of five independent formulation factors such as Eudragit® RS-100 (A), span-80 (B), acetone (C), methanol (D), stirring speed (E) affecting on encapsulation efficiency (EE) and dissolution rate (DR). The developed microspheres were evaluated by Field emission scanning electron microscopy (FE-SEM); particle size analyzer (PSA); Fourier transform infrared spectroscopy (FTIR); X-ray powder diffraction (XRD) and in-vitro drug release as well as microspheres were assessed for accelerated stability. The microspheres obtained were spherical in shape with non-porous surface and the mean particle size was 1.077 µm. FTIR and XRD study confirmed drug-polymer compatibility. EE obtained from all microspheres formulations was found in the range of 61.83–84.77%. 2D contour and 3D surface plots showed potential effects of independent factors on EE and DR. Sustained drug release profile (up to 12 h) was attained by Eudragit® RS100 polymer. Accelerated stability results for attributes like physical appearance and drug content did not showed any significant change over the period. Eudragit® RS-100 polymer could be used as favourable sustained release carrier in developing VLG loaded microspheres for the treatment of hyperglycemia to increase its duration of action. © 2017, The Korean Society of Pharmaceutical Sciences and Technology.
引用
收藏
页码:627 / 637
页数:10
相关论文
共 31 条
[1]  
Behera B.C., Sahoo S.K., Dhal S., Barik B.B., Gupta B.K., Characterization of glipizide-loaded polymath- acrylate microspheres prepared by an emulsion solvent evaporation method, Trop J Pharm Res, 7, pp. 879-885, (2008)
[2]  
Betha S., Reddy B.P., Swamy P.V., Varma M.M., Raju D.B., Kolapalli V.R.M., Dose calculation, design and development of nateglinide matrix tablets using quality by design approach and its pharmacokinetic evaluation in animal model, J Pharm Invest, 45, pp. 515-528, (2015)
[3]  
Deshmukh R.K., Naik J.B., Diclofenac sodium-loaded Eudragit<sup>®</sup> microspheres: optimization using statistical experimental design, J Pharm Innov, 8, pp. 276-287, (2013)
[4]  
Deshmukh R.K., Naik J.B., Aceclofenac microspheres: quality by design approach, Mater Sci Eng, 36, pp. 320-328, (2014)
[5]  
Deshmukh R.K., Naik J.B., The impact of preparation parameters on sustained release aceclofenac microspheres: a design of experiments, Adv Powder Technol, 26, pp. 244-252, (2015)
[6]  
Deshmukh R.K., Naik J.B., Optimization of sustained release aceclofenac microspheres using response surface methodology, Mater Sci Eng, 48, pp. 197-204, (2015)
[7]  
Deshmukh R.K., Naik J.B., Optimization of spray-dried diclofenac sodium-loaded microspheres by screening design, Drying Technol, 34, pp. 1593-1603, (2016)
[8]  
Dewan I., Islam S., Rana M.S., Characterization and compatibility studies of different rate retardant polymer loaded microspheres by solvent evaporation technique: in vitro-in vivo study of Vildagliptin as a model drug, J Drug Delivery, 2015, pp. 1-12, (2015)
[9]  
Duez H., Cariou B., Staels B., DPP-4 inhibitors in the treatment of type 2 diabetes, Biochem Pharmacol, 83, pp. 823-832, (2012)
[10]  
Eudragit RL 100, Eudragit RLPO, Eudragit RS100 and Eudragit RSPO technical information industrial product division, (2015)